Costello Syndrome is a rare genetic disorder characterized by multiple congenital anomalies and developmental delays. It is estimated to affect approximately 1 in every 300,000 to 400,000 individuals worldwide. The prevalence of this syndrome is considered to be low, making it a rare condition. Costello Syndrome is caused by mutations in the HRAS gene and can lead to various health issues, including intellectual disability, heart abnormalities, and distinctive facial features. Early diagnosis and comprehensive medical management are crucial for individuals with Costello Syndrome to optimize their quality of life.
Costello Syndrome is a rare genetic disorder that affects multiple organ systems and is characterized by distinctive facial features, developmental delays, and an increased risk of certain tumors. It is caused by mutations in the HRAS gene.
The prevalence of Costello Syndrome is estimated to be approximately 1 in every 300,000 to 400,000 individuals worldwide. Although it is considered a rare condition, it is important to note that the exact prevalence may vary across different populations and regions.
Costello Syndrome primarily affects individuals of all ethnic backgrounds and both genders equally. The condition is typically diagnosed in infancy or early childhood based on the presence of characteristic symptoms and genetic testing.
Due to its rarity, Costello Syndrome often poses challenges in diagnosis and management. Early intervention and comprehensive medical care are crucial in addressing the various health issues associated with the syndrome.
Research and support organizations play a vital role in advancing our understanding of Costello Syndrome, improving diagnostic methods, and providing resources for affected individuals and their families.